VCEL Vericel Corporation

WallSt.net Airing Exclusive Audio Interviews With CMBV, ACNI and MCEL An In-Depth Article Based on a Recent Interview With ASTM is Also Available Now at www.wallst.net NEW YORK, May 23 /PRNewswire/ -- Gary Fineberg, CEO of Cambodian Ventures Ltd. (Pink Sheets: CMBV) recently granted Wall Street Network an exclusive audio interview profiling the company. Interview highlights include discussions on the following topics: - market opportunity for precious mineral exploration companies in Cambodia - a timeline for the company's activities - relationships with the Cambodian government - overview of management - upcoming milestones To hear the interview in its entirety and to read an in-depth report on the company, visit http://wallst.net/superstock/CMBV/cmbv.html Gordon Lee, CEO of American IDC Corp. (Pink Sheets: ACNI) recently granted Wall Street Network an exclusive interview profiling the company. Interview highlights include detailed discussions on the following topics: - the company's premium SMS services - competitive edge - growth of the U.S. SMS market - initiatives in China - market opportunities - recent acquisitions - upcoming milestones To hear the interview in its entirety, and to read an in-depth report on the company, visit http://wallst.net/superstock/ACNI/acni.html John Battaglini, VP of Sales, Marketing and Project Management for Millennium Cell, Inc. (NASDAQ:MCEL) recently granted Wall Street Network an exclusive audio interview profiling the company. Interview highlights include detailed discussions on the following topics: - recently announced joint development program with Dow Chemical Co., and its impact on the timeline for the commercialization of Millennium Cell's hydrogen-based batteries - operational and strategic highlights from Q1; outlook for 2005 - advantages of the company's hydrogen-based batteries over the current standard - feedback from government and commercial sectors - capitalization - upcoming milestones Wall Street Network is also featuring an in-depth article based on a recent interview with Douglas Armstrong Ph D, Chairman and CEO of Aastrom Biosciences, Inc. (NASDAQ:ASTM). Topics detailed in the article include: - recent clinical trial results in Spain - why the company's cells are "non-controversial" - capitalization - progress with the FDA - timelines for clinical trials - the company's ability to "take a spoon full of bone marrow, and make it look like several quarts of bone marrow, with regards to its tissue regeneration capability" - upcoming clinical milestones To read the article and hear the interviews in their entirety, visit http://www.wallst.net/. The interviews can be accessed by locating the respective company's ticker symbol under the exchange on which it trades on the left hand column of the homepage, or by entering the respective company's ticker symbol in the Audio Search window. About Wall Street Network Wall Street Network is owned and licensed by Wall Street Direct, Inc. All material herein was prepared by Digital Wall Street, Inc., a multimedia provider of original, insightful commentary and news from North America's leading publicly traded companies giving a direct link to the management of today's fastest-growing companies through encompassing executive interviews and sector seminars. The company provides a free service to consumers, and a paid, premium monthly subscription to its members. Digital Wall Street, Inc. has received two million free trading shares of CMBV from a third party for press and advertising materials for CMBV. Digital Wall Street, Inc. has received two thousand five hundred dollars from ACNI for press and advertising services, and is expecting to receive seventeen million restricted shares from the company for press and advertising services for a separate contract. For a complete list of our business relationships, visit http://www.wallst.net/disclaimer.asp . Contact: Nick Iyer Digital Wall Street, Inc. 800-4-WALL-ST DATASOURCE: Wall Street Network CONTACT: Nick Iyer of Digital Wall Street, Inc., +1-800-4-WALL-ST, for Wall Street Network Web site: http://www.wallst.net/

Copyright